IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease - Wikidata - awgldk - TriplyDB

IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease

IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease

http://www.wikidata.org/entity/Q38728766

about

Regulation of Natural Killer Cell Function by STAT3 Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity From genotype to functional phenotype: unraveling the metabolomic features of colorectal cancer.Indoleamine 2,3-Dioxygenase Is Not a Pivotal Regulator Responsible for Suppressing Allergic Airway Inflammation through Adipose-Derived Stem Cells.Fate of dietary tryptophan in young Japanese women.NK Cell-Dependent Growth Inhibition of Lewis Lung Cancer by Yu-Ping-Feng, an Ancient Chinese Herbal Formula L-tryptophan metabolism in pregnant mice fed a high L-tryptophan diet and the effect on maternal, placental, and fetal growth.Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.Danger signalling during cancer cell death: origins, plasticity and regulation.Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications.

P2860

Q26752551-5A5F1F6C-5BB1-49AA-A0AC-926C0DD789EB Q26862220-7CD17842-CCFA-4DD7-9F45-0A1DFE1EF7AB Q34347646-359E7567-94ED-459F-BDFE-E476A953B951 Q36182258-B353E116-18FF-4CCF-A8B5-1F2DCCFAF35D Q36387696-87890B9A-12ED-4C73-9B09-BC08E408D15B Q36681210-4E4A6F45-8C32-4DB2-B1B2-90B765F30AC1 Q37106900-B2B6D6F1-161E-48CC-A338-6C488FA7E0CF Q37115673-E39FF41B-6C40-4C4F-B382-2BB511DB58D9 Q37381745-283B076C-6C57-41E9-876E-1B482E2EB017 Q41712406-C936C6BC-581C-4308-BF88-9A3A7B3793F4 Q47759599-1D8F960A-C8AE-4F38-93D5-F0C62E8DD247

P2860

IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease

http://www.wikidata.org/entity/Q38728766

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease

@en

type

label

IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease

@en

prefLabel

IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease

@en

P1433

Q38728766-DAF38465-483A-4220-9393-DBD5293BB5FC

P1476

Q38728766-E179154D-4061-44D8-B83F-26ACD93AE945

P2093

Q38728766-13217028-A4BA-473C-A459-E75FCAAC71F6

Q38728766-4FEB73A7-103A-4543-9DC1-52FB9DB1313B

Q38728766-9352AEA0-FC6C-4192-BFCD-578FB031DE74

Q38728766-AD2B0702-0AB4-4B54-AFC5-BD9B214F6570

Q38728766-CA5A83B0-AAE3-424B-A4DF-F860B366A122

Q38728766-E1CEA781-6DC8-4BCD-933B-D06B77457E49

P2860

Q38728766-03BB43A7-325C-4479-80A1-9BB98D874F4C

Q38728766-15307A78-285D-4FFB-9C9E-FA4A88307BB0

Q38728766-186125D7-5F17-49DA-9EFB-32EE2962B601

Q38728766-1A797297-A894-4A6F-A818-E877035DEDEE

Q38728766-1C42D77E-DEE2-4C14-A6A1-963891487A5B

Q38728766-1F4C1FB6-99F9-437D-BD19-01106DC0EF7D

Q38728766-1F60ECD1-E3B0-4BA2-86D6-39F3477B7E7A

Q38728766-2A002801-1D3C-4578-AFB9-41E7A2CA442D

Q38728766-2E4C6ACB-A1D5-4955-A61F-32BAF22EA783

Q38728766-2F96049C-3D66-4954-8F20-C4533644F94A

P304

Q38728766-3973493C-9341-424A-9E3B-32C1F39C1589

P31

Q38728766-77ECB00B-AE9E-4A19-B957-D4156ECEECD5

P356

Q38728766-7DA178E1-DDE6-417E-9FEF-29EC0F5DE8FB

P478

Q38728766-8835EFE3-25A4-4586-8F8E-165BD08E522D

P50

Q38728766-AB185E65-449C-49D8-B132-0D41FFFED9B8

Q38728766-B9A3A674-30AC-4D3A-BF8B-E3367C73BAC3

P577

Q38728766-53B3A216-5BB1-4E56-B3BD-CB861DD9EDC9

P698

Q38728766-B13D1FB1-5208-4D6F-BD99-BE5AD4EC1E94

P932

Q38728766-2D0683A4-D590-44C1-A7E0-0F383646B1D6

P356

P1433

International journal of tryptophan research : IJTR

P1476

IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease

@en

P2093

Dietmar Fuchs

http://www.w3.org/2001/XMLSchema#string

Gerald Brandacher

http://www.w3.org/2001/XMLSchema#string

Guenter Weiss

http://www.w3.org/2001/XMLSchema#string

Katharina Kurz

http://www.w3.org/2001/XMLSchema#string

Raimund Margreiter

http://www.w3.org/2001/XMLSchema#string

Robert Sucher

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

Prevention of allogeneic fetal rejection by tryptophan catabolism

Inhibition of T cell proliferation by macrophage tryptophan catabolism

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma

Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway.

L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase.

P304

113-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4137/IJTR.S4157

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Gerald Brandacher

P577

2010-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22084593

http://www.w3.org/2001/XMLSchema#string

P932

3195236

http://www.w3.org/2001/XMLSchema#string